Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-03-06 @ 3:02 AM
Study NCT ID:
NCT02593292
Status:
COMPLETED
Last Update Posted:
2025-09-03
First Post:
2015-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics
Sponsor:
Hospices Civils de Lyon
Organization:
Study Overview
Official Title:
Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics
Status:
COMPLETED
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROSPERO
Brief Summary:
This French multicentre open-label randomized trial will test the hypothesis that a coordinated health circuit based on obstetric risks, backed up by an electronic patient care reporting information system will optimize the continuum of pregnancy care monitoring. The electronic patient care reporting information system will be shared between patients, private practice physicians/midwifes, hospital physicians/midwifes and supervised by a coordinating midwife.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: